RxDoctor Payments Data

Donna White

Family · Lawrenceburg, TNNPI 1154751659

Payments from drug & device makers

$2,380in general payments, 2019–2025

Across 152 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$676
  • Novo Nordisk$559
  • AstraZeneca$468
  • Lilly USA, LLC$211
  • Pfizer$151
  • Bayer$86
  • plus $229 from 8 others

What the payments were for

  • Food & beverage$2,380100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,380 in reported general payments places this provider in the 80th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$1,477
Medicare patients
43
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin92$106,902
OzempicSemaglutide79$88,372
RybelsusSemaglutide60$83,782
MounjaroTirzepatide24$27,116
TrulicityDulaglutide20$26,075
EliquisApixaban21$21,095
JanuviaSitagliptin Phosphate13$12,360
LinzessLinaclotide13$11,246
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$10,228
Tresiba Flextouch U-200Insulin Degludec17$8,556
Tresiba Flextouch U-100Insulin Degludec11$5,324
Ezetimibe128$4,209
Verapamil Er PmVerapamil Hcl12$4,155
HumalogInsulin Lispro11$3,444
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$2,648

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$559$172,153139 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog$211$56,63655 claims
PfizerEliquis$151$21,09521 claims
AbbVieLinzess$676$11,24613 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$13$1,643211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,706 family providers in Tennessee.

Other family in Lawrenceburg

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →